Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/05/12 | Current report filing |
|
6 | ||
| 09/10/12 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
5 | |
| 08/15/12 | Prospectus filed pursuant to Rule 424(b)(3) |
|
31 | ||
| 08/14/12 | Quarterly report pursuant to Section 13 or 15(d) |
|
42 | ||
| 08/09/12 | Initial statement of beneficial ownership of securities |
|
3 | ||
| 08/07/12 | Current report filing |
|
11 | ||
| 06/21/12 | Current report filing |
|
2 | ||
| 05/16/12 | Prospectus filed pursuant to Rule 424(b)(3) |
|
29 | ||
| 05/15/12 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
33 | |
| 05/15/12 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |